Search research articles
Contact Us
Filters
Showing results (161-170 of 237) with videos related to
Page
of 24
Sort By:
Annals of Neurology
|
February 28, 2012
Prognosis of coma after therapeutic hypothermia: a prospective cohort study
Aline Bouwes, Jan M Binnekade, Michael A Kuiper, et al.
Stroke
|
March 16, 2018
Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease
Esther M C van Leijsen, H Bea Kuiperij, Iris Kersten, et al.
Neuro-Oncology Advances
|
October 25, 2021
Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes
Anna E M Bastiaansen, Adriaan H C de Jongste, Marienke A A M de Bruijn, et al.
Journal of Neurochemistry
|
September 11, 2012
Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome
Myrthe Rouwette, Klaartje Somers, Cindy Govarts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 26, 2018
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
Oskar Hansson, Alvydas Mikulskis, Anne M Fagan, et al.
Alzheimer'S Research & Therapy
|
September 25, 2021
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy
Anna M De Kort, H Bea Kuiperij, Daniel Alcolea, et al.
The Lancet. Neurology
|
June 16, 2009
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
Pieter Jelle Visser, Frans Verhey, Dirk L Knol, et al.
Alzheimer'S Research & Therapy
|
January 31, 2023
Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy
Marc Vervuurt, Anna M de Kort, Lieke Jäkel, et al.
Journal of Neurochemistry
|
February 16, 2024
Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy
Emma van den Berg, Iris Kersten, Gunnar Brinkmalm, et al.
Neurology
|
December 2, 2016
β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy
Ellis S van Etten, Marcel M Verbeek, Jeroen van der Grond, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 237) with videos related to
Sort By:
Page
of 24
Annals of Neurology
|
February 28, 2012
Prognosis of coma after therapeutic hypothermia: a prospective cohort study
Aline Bouwes, Jan M Binnekade, Michael A Kuiper, et al.
Stroke
|
March 16, 2018
Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease
Esther M C van Leijsen, H Bea Kuiperij, Iris Kersten, et al.
Neuro-Oncology Advances
|
October 25, 2021
Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes
Anna E M Bastiaansen, Adriaan H C de Jongste, Marienke A A M de Bruijn, et al.
Journal of Neurochemistry
|
September 11, 2012
Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome
Myrthe Rouwette, Klaartje Somers, Cindy Govarts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 26, 2018
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
Oskar Hansson, Alvydas Mikulskis, Anne M Fagan, et al.
Alzheimer'S Research & Therapy
|
September 25, 2021
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy
Anna M De Kort, H Bea Kuiperij, Daniel Alcolea, et al.
The Lancet. Neurology
|
June 16, 2009
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
Pieter Jelle Visser, Frans Verhey, Dirk L Knol, et al.
Alzheimer'S Research & Therapy
|
January 31, 2023
Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy
Marc Vervuurt, Anna M de Kort, Lieke Jäkel, et al.
Journal of Neurochemistry
|
February 16, 2024
Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy
Emma van den Berg, Iris Kersten, Gunnar Brinkmalm, et al.
Neurology
|
December 2, 2016
β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy
Ellis S van Etten, Marcel M Verbeek, Jeroen van der Grond, et al.
Page
of 24